Js Capital Management LLC Adverum Biotechnologies, Inc. Transaction History

Js Capital Management LLC

  • $199 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$9.84 - $14.26 $112,176 - $162,564
-11,400 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$10.3 - $21.64 $117,420 - $246,696
11,400 New
11,400 $117,000

Others Institutions Holding ADVM

# of Institutions
3
Shares Held
524K
Call Options Held
0
Put Options Held
0
View Full List

About Adverum Biotechnologies, Inc.

ADVM Quotes by TradingView
  • Ticker ADVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,333,600
  • Market Cap $681M
  • Description
  • Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...
More about ADVM
Track This Portfolio

Track Js Capital Management LLC Portfolio

Follow Js Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Js Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Js Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email